BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 22541406)

  • 1. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model.
    Quan SH; Zhang YL; Han DH; Iwakura Y; Rhee CS
    Ann Allergy Asthma Immunol; 2012 May; 108(5):342-50. PubMed ID: 22541406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Interleukin-17A on the Chemotactic Responses to CCL7 in a Murine Allergic Rhinitis Model.
    Zhang YL; Han DH; Kim DY; Lee CH; Rhee CS
    PLoS One; 2017; 12(1):e0169353. PubMed ID: 28046055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of experimental allergic rhinitis with suppression of topical immune responses by lack of IL-27/WSX-1 signaling.
    Shimanoe Y; Miyazaki Y; Hara H; Inokuchi A; Yoshida H
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):223-32. PubMed ID: 19354069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
    Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
    Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of allergic inflammation in murine model of rhinitis by different bacterial ligands: involvement of mast cells and dendritic cells.
    Yamamoto K; Kawamura I; Ito J; Mitsuyama M
    Clin Exp Allergy; 2006 Jun; 36(6):760-9. PubMed ID: 16776677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model.
    Cho KS; Park HK; Park HY; Jung JS; Jeon SG; Kim YK; Roh HJ
    Stem Cells; 2009 Jan; 27(1):259-65. PubMed ID: 18832595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells.
    Aoi N; Masuda T; Murakami D; Yajima T; Mizubuchi H; Yamada H; Kawauchi H; Yoshikai Y
    J Allergy Clin Immunol; 2006 Jun; 117(6):1359-66. PubMed ID: 16750998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role of IL-33 in experimental allergic rhinitis.
    Haenuki Y; Matsushita K; Futatsugi-Yumikura S; Ishii KJ; Kawagoe T; Imoto Y; Fujieda S; Yasuda M; Hisa Y; Akira S; Nakanishi K; Yoshimoto T
    J Allergy Clin Immunol; 2012 Jul; 130(1):184-94.e11. PubMed ID: 22460070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis.
    Shin JH; Park HR; Kim SW; Park CS; Cho JH; Park YJ; Kim SW
    Am J Rhinol Allergy; 2012; 26(2):e71-5. PubMed ID: 22487280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking interleukin-17 attenuates enhanced inflammation by staphylococcal enterotoxin B in murine allergic rhinitis model.
    Moon IJ; Hong SL; Kim DY; Lee CH; Rhee CS; Min YG
    Acta Otolaryngol; 2012 Jun; 132 Suppl 1():S6-12. PubMed ID: 22582785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice.
    Farraj AK; Harkema JR; Kaminski NE
    Toxicol Sci; 2004 Jun; 79(2):315-25. PubMed ID: 15056815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hypoxia-inducible factor 1α in allergic rhinitis.
    Mo JH; Kim JH; Lim DJ; Kim EH
    Am J Rhinol Allergy; 2014; 28(2):e100-6. PubMed ID: 24717944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.
    Dubois A; Deruytter N; Adams B; Kanda A; Delbauve S; Fleury S; Torres D; François A; Pétein M; Goldman M; Dombrowicz D; Flamand V
    J Immunol; 2010 Jul; 185(2):884-91. PubMed ID: 20562264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An essential role for dendritic cells in human and experimental allergic rhinitis.
    KleinJan A; Willart M; van Rijt LS; Braunstahl GJ; Leman K; Jung S; Hoogsteden HC; Lambrecht BN
    J Allergy Clin Immunol; 2006 Nov; 118(5):1117-25. PubMed ID: 17088138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A.
    Besnard AG; Sabat R; Dumoutier L; Renauld JC; Willart M; Lambrecht B; Teixeira MM; Charron S; Fick L; Erard F; Warszawska K; Wolk K; Quesniaux V; Ryffel B; Togbe D
    Am J Respir Crit Care Med; 2011 May; 183(9):1153-63. PubMed ID: 21297073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 controls Th2-type cytokine production and eosinophil infiltration in a mouse model of allergic airway inflammation.
    Kosaka S; Tamauchi H; Terashima M; Maruyama H; Habu S; Kitasato H
    Immunobiology; 2011 Jul; 216(7):811-20. PubMed ID: 21257225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
    Benson M; Strannegård IL; Strannegård O; Wennergren G
    J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation.
    KleinJan A; Willart M; van Nimwegen M; Leman K; Hoogsteden HC; Hendriks RW; Lambrecht BN
    Clin Exp Allergy; 2010 Mar; 40(3):494-504. PubMed ID: 19968652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
    Bui TT; Piao CH; Song CH; Chai OH
    Int Immunopharmacol; 2017 Nov; 52():77-84. PubMed ID: 28886581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.